Company Email Format Management

PEP-Therapy

Biotechnology Research Paris, Fr 14 employees

Employees: 14
Contacts: 2
Emails: 2

pep-therapy.com LinkedIn Crunchbase

PEP-Therapy Overview

Headquarters: Paris, Fr
Phone Number: Available in AeroLeads
Website: pep-therapy.com
Industry: Biotechnology Research
Employees: 14
Founded: 2014
Funding: 1.9M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

cell penetrating peptide protein-protein interaction targeted therapies oncology clinical trial cancer

About PEP-Therapy

PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors.

PEP-Therapy Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

PEP-Therapy Org Chart

Sample employees and titles

Name	Title	Location	Contact
Denis Ravel	Founder and Managing Director	Greater Paris Metropolitan Region, France	Email
Giovanni Longhi	CFO - Business Advisor - Business Angel	Milan, Lombardy, Italy	Email
Michele Marzola	Co-founder and Chief Executive Officer		View